Insider Stock Trading History of Olanoff Lawrence S


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Olanoff Lawrence S since year 2005. The trader's CIK number is 1224341. At the time of this reporting, Olanoff Lawrence S is the Director of Ironwood Pharmaceuticals Inc . (stock ticker symbol IRWD). See this page for all insider trading activities at Ironwood Pharmaceuticals Inc .

Note that in the past OLANOFF LAWRENCE S also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Olanoff Lawrence S since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-03-05 IRWD Ironwood Pharmaceuticals Inc Sale 2,000 14.05 28,100
2017-12-04 IRWD Ironwood Pharmaceuticals Inc Sale 2,000 16.29 32,570
2017-09-05 IRWD Ironwood Pharmaceuticals Inc Sale 2,000 16.15 32,299
2017-06-08 IRWD Ironwood Pharmaceuticals Inc Sale 3,200 17.78 56,896
2016-12-05 IRWD Ironwood Pharmaceuticals Inc Sale 3,200 15.68 50,176
2016-09-06 IRWD Ironwood Pharmaceuticals Inc Sale 3,200 13.72 43,904
2016-06-03 IRWD Ironwood Pharmaceuticals Inc Sale 2,200 12.92 28,424
2016-03-07 IRWD Ironwood Pharmaceuticals Inc Sale 2,200 11.11 24,442
2015-12-07 IRWD Ironwood Pharmaceuticals Inc Sale 2,200 11.77 25,894
2015-09-04 IRWD Ironwood Pharmaceuticals Inc Sale 3,725 10.97 40,863
2013-08-26 FRX Forest Laboratories Inc Sale 1,104 42.96 47,431
2013-03-04 FRX Forest Laboratories Inc Sale 543 36.77 19,967
2012-09-05 FRX Forest Laboratories Inc Sale 561 34.90 19,580
2012-03-07 FRX Forest Laboratories Inc Sale 561 32.39 18,173
2005-11-14 CLN Celsion Corp Buy 76,645 .33 24,986
2005-11-14 CLN Celsion Corp Buy 76,645 .33 24,986

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Olanoff Lawrence S (Director of Ironwood Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.